The implant technology, developed by Genetech and Roche, is designed to continuously deliver medication into the eyes, subsequently avoiding the need for ongoing anti-VEGF Read more
mark?ennovy obtains European clearance for myopia control contact
The product – developed in conjunction with the Sydney-based Brien Holden Vision Institute (BHVI) – could be made available to Australian optometrists as soon Read more
MDFA to distribute toolkits ahead of Macula Month
Spanning the month of May, the organisation is urging eyecare professionals to support Macula Month, and will commence its campaign by providing digital imagery Read more
Ellex reports positive results in first-line glaucoma treatment
In newly-released results from the LiGHT study, the Australian medical device manufacturer revealed its SLT therapy provided better intraocular pressure (IOP) stability than IOP-lowering Read more
OA plans to ?inundate? MPs ahead of election
With an election likely to take place in May, OA has launched a campaign calling for all sides of government to support its plans Read more
Warnings about using smartphones in eye examinations
According to research published in Scientific Reports, the colours in images captured by smartphone cameras may be inaccurate if the camera is not correctly Read more
Funding for device to revolutionise corneal ulcer treatment
The iFix corneal pen releases a form of bioink directly onto the eye to help corneal cell regenerate and create a biological barrier to Read more
Tax authorities to target eyecare sector
The note cited a case in which the Victorian State Revenue Office had recently raised amended assessments for a large optometry practice, and warned Read more
MDFA releases $600,000 in new grants to tackle macular disease
The Macular Disease Foundation Australia (MDFA) has awarded $600,000 in new research grants to advance research into Indigenous diabetic vision loss, sub-retinal fibrosis and novel disease detection methods. Read more
Aussie tear test could diagnose diabetes complication
A potential biomarker located in the eye for a debilitating complication of diabetes could be the key to future development of a new point-of-care screening device. Read more